Desloratadine Inhibits Human Skin Mast Cell Activation and Histamine Release

This publication has 11 references indexed in Scilit:

• Update on chronic urticaria: focusing on mechanisms
  Current Opinion in Allergy and Clinical Immunology, 2008
• Mast cell functions in the innate skin immune system
  Immunobiology, 2008
• Inhibition of allergen‐induced wheal and flare reactions by levocetirizine and desloratadine
  British Journal of Clinical Pharmacology, 2007
• Mast cells – key effector cells in immune responses
  Trends in Immunology, 2007
• Inhibition of nasal polyp mast cell and eosinophil activation by desloratadine
  Allergy, 2005
• Inhibitory effects of budesonide, desloratadine and dexamethasone on cytokine release from human mast cell line (HMC-1)
  Inflammation Research, 2004
• Desloratadine prevents compound 48/80‐induced mast cell degranulation: visualization using a vital fluorescent dye technique
  Allergy, 2004
• LAMP‐1 and LAMP‐2, but not LAMP‐3, are reliable markers for activation‐induced secretion of human mast cells
  Cytometry Part A, 2004
• Inhibition of cytokine secretion from human leukemic mast cells and basophils by H₁‐ and H₂‐receptor antagonists
  Experimental Dermatology, 2000
• Loratadine and desethoxylcarbonyl‐loratadine inhibit the immunological release of mediators from human FcɛRI⁺cells
  Clinical & Experimental Allergy, 1997